Atorvastatin and Diabetic Vascular Complications

E-ISSN： 1873-4286|12|12|1549-1554

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.12, 2006-04, pp. : 1549-1554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2613-2618

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy

Current Pharmaceutical Design, Vol. 11, Iss. 18, 2005-07 ,pp. : 2279-2299

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets of Diabetic Vascular Complications and Potential New Drugs

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 503-509

Bentham Science Publishers

Access to resources Recommend Favorite

Herbal Medicines and Nutraceuticals for Diabetic Vascular Complications: Mechanisms of Action and Bioactive Phytochemicals

Current Pharmaceutical Design, Vol. 16, Iss. 34, 2010-11 ,pp. : 3776-3807

Bentham Science Publishers

Access to resources Recommend Favorite

A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1759-1764

Bentham Science Publishers

Access to resources Recommend Favorite